Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical evaluation of oral levofloxacin 500 mg once-daily dosage for treatment of lower respiratory tract infections and urinary tract infections: a prospective multicenter study in China.
Zhang YY, Huang HH, Ren ZY, Zheng HG, Yu YS, Lü XJ, Xiao ZK, Yang HF, Xiu QY, Chen BY, Yue HM, Hao QL, Huang JA, Ma H, Xiao W, Guo DY, Si B, Sun SH, Zhang W, Li QH, Shen HH, Duan J, Li HY, Yao WZ, Gu JM, Xia QM, Ying KJ, Liu A, Yang HP, Shi MH, Sun TY, Ding GH, Wu GM. Zhang YY, et al. Among authors: xiao zk, xiao w. J Infect Chemother. 2009 Oct;15(5):301-11. doi: 10.1007/s10156-009-0713-9. Epub 2009 Oct 24. J Infect Chemother. 2009. PMID: 19856068 Clinical Trial.
Population pharmacokinetics of oral levofloxacin 500 mg once-daily dosage in community-acquired lower respiratory tract infections: results of a prospective multicenter study in China.
Zhang J, Xu JF, Liu YB, Xiao ZK, Huang JA, Si B, Sun SH, Xia QM, Wu XJ, Cao GY, Shi YG, Zhang YY. Zhang J, et al. Among authors: xiao zk. J Infect Chemother. 2009 Oct;15(5):293-300. doi: 10.1007/s10156-009-0714-8. Epub 2009 Oct 24. J Infect Chemother. 2009. PMID: 19856067 Clinical Trial.
A randomized controlled clinical trial of levofloxacin 750 mg versus 500 mg intravenous infusion in the treatment of community-acquired pneumonia.
Zhao X, Wu JF, Xiu QY, Wang C, Zhang DP, Huang JA, Xie CM, Sun SH, Lv XJ, Si B, Xiao ZK, Zhang YY. Zhao X, et al. Among authors: xiao zk. Diagn Microbiol Infect Dis. 2014 Oct;80(2):141-7. doi: 10.1016/j.diagmicrobio.2013.11.008. Epub 2013 Nov 15. Diagn Microbiol Infect Dis. 2014. PMID: 25130297 Clinical Trial.
A randomized, double-blind, multicenter Phase II study comparing the efficacy and safety of oral nemonoxacin with oral levofloxacin in the treatment of community-acquired pneumonia.
Liu Y, Zhang Y, Wu J, Zhu D, Sun S, Zhao L, Wang X, Liu H, Ren Z, Wang C, Xiu Q, Xiao Z, Cao Z, Cui S, Yang H, Liang Y, Chen P, Lv Y, Hu C, Lv X, Liu S, Kuang J, Li J, Wang D, Chang L. Liu Y, et al. J Microbiol Immunol Infect. 2017 Dec;50(6):811-820. doi: 10.1016/j.jmii.2015.09.005. Epub 2015 Dec 1. J Microbiol Immunol Infect. 2017. PMID: 26748734 Free article. Clinical Trial.
A multicentre, randomised, double-blind, double-dummy, parallel-controlled, phase 3 clinical trial assessing the efficacy and safety of intravenous nemonoxacin malate vs. levofloxacin for community-acquired pneumonia in adult patients.
Li Y, Zhu D, Sun S, Chang X, Cao Z, Yang Y, Fu X, Li X, Xu J, Zhu Y, Hui F, Xu X, Chen Z, Peng L, Ma Z, Mo B, Li C, Lv Y, Zhao L, Zhu G, He Y, Liu H, Chen J, Wang Y, Liang Y, Lu Y, Qin Z, Yang H, Zhang M, Wu S, Tong Z, Ye F, Xiao Z, Wang X, Qiu C, Kuang J, Huang H, Wang K, Ying K, Jin F, Lv X, Huang Y, Liu D, Wang W, Zhang Y. Li Y, et al. Int J Antimicrob Agents. 2024 Aug;64(2):107235. doi: 10.1016/j.ijantimicag.2024.107235. Epub 2024 Jun 6. Int J Antimicrob Agents. 2024. PMID: 38851462 Free article. Clinical Trial.
27 results